Mode of spread in the early phase of lymphatic metastasis in non-small-cell lung cancer: significance of nodal micrometastasis
- PMID: 8800148
- DOI: 10.1016/S0022-5223(96)70044-2
Mode of spread in the early phase of lymphatic metastasis in non-small-cell lung cancer: significance of nodal micrometastasis
Abstract
The impact of lymphatic micrometastases on prognosis of non-small-cell lung cancer has not been clearly established. We therefore prospectively assessed the frequency, mode of mediastinal spread, and prognostic significance of lymphatic micrometastases in lymph nodes of 93 patients with completely resected non-small-cell lung cancer staged as pT1 to pT4 pN0 and pN1 by conventional histopathologic techniques. Frozen tissue sections from 471 lymph nodes that were staged as free of metastases by routine histopathologic examination were screened for micrometastases by the alkaline phosphatase-antialkaline phosphatase immunostaining technique with the monoclonal antibody Ber-Ep-4. Twenty of 73 patients (27.4%) with disease staged as pN0 and nine of 20 patients (45.0%) with disease staged as pN1 had nodal micrometastases. Eight of 17 patients with upper lobe primary tumors and five of 12 patients with lower lobe primary tumors exhibited skip micrometastases. Mean relapse-free survival was significantly increased in patients with pN0 disease without micrometastases (41.1 vs 29 months, p = 0.0081). In patients with pN1 disease, mean relapse-free and cancer-related survivals were also significantly increased if no micrometastases were found (34.8 and 38.2 months vs 18 and 23.5 months, p = 0.0157 and p = 0.0094). Patients with disease staged as pN0 and pN1 with micrometastases revealed no difference in cancer-related survival compared with a control population of patients with disease staged as pN2. The mode of spread was erratic. The prognosis of patients after upstaging of pN0 and pN1 disease according to results of immunohistochemical staining correlated strongly with the prognosis of patients whose disease was staged at the higher stages by conventional histopathologic examination. These findings could represent a new indication for adjuvant therapy, supporting extensive lymph node sampling for staging purposes.
Similar articles
-
Skip metastasis in nonsmall cell lung carcinoma: predictive markers and isolated tumor cells in N1 lymph nodes.Cancer. 2004 May 1;100(9):1909-17. doi: 10.1002/cncr.20165. Cancer. 2004. PMID: 15112272
-
Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non-small-cell lung cancer.J Clin Oncol. 1994 Sep;12(9):1827-32. doi: 10.1200/JCO.1994.12.9.1827. J Clin Oncol. 1994. PMID: 8083707
-
Metastasis to subsegmental and segmental lymph nodes in patients resected for non-small cell lung cancer: prognostic impact.Ann Thorac Surg. 2014 Mar;97(3):987-92. doi: 10.1016/j.athoracsur.2013.11.051. Epub 2014 Jan 28. Ann Thorac Surg. 2014. PMID: 24480258
-
ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer.Eur J Cardiothorac Surg. 2006 Nov;30(5):787-92. doi: 10.1016/j.ejcts.2006.08.008. Epub 2006 Sep 12. Eur J Cardiothorac Surg. 2006. PMID: 16971134
-
Clinical significance of micrometastasis in lung and esophageal cancer: a new paradigm in thoracic oncology.Ann Thorac Surg. 2002 Jul;74(1):278-84. doi: 10.1016/s0003-4975(01)03376-8. Ann Thorac Surg. 2002. PMID: 12118789 Review.
Cited by
-
Incidence and clinical relevance of non-small cell lung cancer lymph node micro-metastasis detected by staging endobronchial ultrasound-guided transbronchial needle aspiration.J Thorac Dis. 2019 Aug;11(8):3650-3658. doi: 10.21037/jtd.2019.05.36. J Thorac Dis. 2019. PMID: 31559073 Free PMC article.
-
Effect of histologic type on recurrence pattern in radiation therapy for medically inoperable patients with stage I non-small-cell lung cancer.Lung. 2006 Nov-Dec;184(6):347-53. doi: 10.1007/s00408-006-0012-5. Epub 2006 Nov 3. Lung. 2006. PMID: 17086466 Clinical Trial.
-
Lymphnodal micrometastases in NSCLC: where do we stand?Lung Cancer Manag. 2016 Jun;5(2):53-55. doi: 10.2217/lmt-2016-0009. Epub 2016 May 24. Lung Cancer Manag. 2016. PMID: 30643549 Free PMC article. No abstract available.
-
Cyclin D1 overexpression is an indicator of poor prognosis in resectable non-small cell lung cancer.Br J Cancer. 1999 Sep;81(1):127-32. doi: 10.1038/sj.bjc.6690661. Br J Cancer. 1999. PMID: 10487623 Free PMC article.
-
Lymph node micrometastases are associated with disease recurrence and poor survival for early-stage non-small cell lung cancer patients: a meta-analysis.J Cardiothorac Surg. 2016 Feb 16;11:28. doi: 10.1186/s13019-016-0427-x. J Cardiothorac Surg. 2016. PMID: 26883746 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous